BiVictriX Therapeutics Company
Biotech focused on developing novel, highly-selective, bispecific ADCs to target unmet need in blood cancer.
Industry:
PharmTech
Headquarters:
Alderley Edge, Cheshire, United Kingdom
Founded Date:
2016
Employees Number:
1-10
Funding Status:
Seed
Investors Number:
2
Last Funding Date:
08-19-2019
Last Funding Type:
Seed
Register and Claim Ownership